WuXi Vaccines Passes First GMP Audit by a Global Vaccine Leader

SUZHOU, China, Dec. 6, 2023 /PRNewswire/ — WuXi Vaccines, a leading global vaccine CDMO (Contract Development and Manufacturing Organization), today announced it has successfully passed an on-site GMP audit by a global vaccine leader at its first standalone CDMO site in Suzhou, China….